Learn about NTSI, a 90% global equity/60% US Treasury ETF, its risk-adjusted return potential, and 2022-style risks—see if it fits your portfolio.
24/7 Wall St. on MSN
Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026
Triple-leveraged ETFs aren’t for everyone, but if you believe biotech is about to break out, Direxion Daily S&P Biotech Bull ...
Themes ETFs launches six new 2x daily leveraged single-stock ETFs, expanding exposure to rare earths, energy, crypto mining ...
The Chosun Ilbo on MSN
Financial Services Commission reviews 3x leveraged ETFs to lure domestic investors
Financial authorities are reviewing measures to ease domestic regulations on exchange-traded funds (ETFs) to the level of ...
Defiance ETFs launched 2X daily ETFs targeting Rocket Companies and space stock Intuitive Machines, offering high-risk, short ...
Invesco Senior Loan ETF (BKLN) is passively managed, tracking the Morningstar LSTA US Leveraged Loan 100 Index. See more ...
The new ETFs are tailored to target a 200% exposure to the daily performance of their underlying stocks, offering sophisticated traders and the retail investor efficient tools to help capitalize on ...
The Wall Street Journal reported last week that “Popular Leveraged Funds Shock Investors With Huge Losses.” It is important to understand how to offer such instruments consistent with regulatory ...
"If somebody launched a 5x Nvidia product tomorrow, it would probably get half a million dollars overnight. The appetite for degenerate leverage is pretty strong right now," Nadig told MarketWatch.
LongPoint launches nine 2X Leveraged ETFs LongPoint's new Savvy ETFs hold large-cap, actively traded Canadian stocks LongPoint is a Canadian owned and operated ETF provider The Savvy ETFs seek daily ...
Beta measures price volatility relative to the S&P 500; beta is calculated from five-year weekly returns. The 1-yr return represents total return over the trailing 12 months. TQQQ charges a marginally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results